Haleon (MEX:HLNN) Market Cap: MXN676,718 Mil (As of Jun. 24, 2026)


MEX:HLNN Haleon PLC MEX:HLNN
74 GF Score
Price MXN99.17
GF Value MXN107.88
! 3 Warning Signs
View Full Analysis

What is Haleon Market Cap?

Haleon MEX:HLNN 74 Market Cap is MXN676,718 Mil as of Jun. 24, 2026. GuruFocus rates MEX:HLNN with a GF Score™ of 74/100 and a GF Value™ of MXN107.88. The stock has 3 warning signs investors should review. Among 1,023 Drug Manufacturers companies, Haleon ranks better than 97.85% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Haleon's share price for the quarter that ended in Dec. 2025 was MXN99.17. Haleon's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 8,905 Mil. Therefore, Haleon's market cap for the quarter that ended in Dec. 2025 was MXN883,139 Mil.

Haleon's quarterly market cap increased from Dec. 2024 (MXN597,718 Mil) to Jun. 2025 (MXN890,954 Mil) but then declined from Jun. 2025 (MXN890,954 Mil) to Dec. 2025 (MXN883,139 Mil).

Haleon's annual market cap declined from Dec. 2023 (MXN608,980 Mil) to Dec. 2024 (MXN597,718 Mil) but then increased from Dec. 2024 (MXN597,718 Mil) to Dec. 2025 (MXN883,139 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Haleon's Enterprise Value for Today is MXN846,584 Mil.


Haleon  (MEX:HLNN) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Haleon Market Cap Related Terms


Haleon Market Cap Historical Data

* Premium members only.

The historical data trend for Haleon's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Haleon Market Cap Chart

Haleon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial 0.00 609,666.58 608,979.97 597,718.41 883,139.20

Haleon Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 608,979.97 602,227.90 597,718.41 890,953.59 883,139.20

MEX:HLNN vs ZTS, UTHR, VTRS: Market Cap Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Haleon's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Haleon Market Cap vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Haleon's Market Cap distribution charts can be found below:

* The bar in red indicates where Haleon's Market Cap falls into.


MEX:HLNN
74GF Score
Haleon PLC MEX:HLNN
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Haleon Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Haleon's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=MXN99.17*8905.306
=MXN883,139

Haleon's Market Cap for the quarter that ended in Dec. 2025 is calculated as

Market Cap (Q: Dec. 2025 )=Share Price (Q: Dec. 2025 )*Shares Outstanding (EOP) (Q: Dec. 2025 )
=MXN99.17*8905.306
=MXN883,139

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of MXN676,718 Mil mean?
Haleon (MEX:HLNN) has a Market Cap of MXN676,718 Mil as of Jun. 24, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Haleon and its competitors. According to the industry distribution chart, Haleon ranks #22 out of 1023 companies in the Drug Manufacturers industry, placing it in the top 2.2%.
Is Haleon's Market Cap too high?
Haleon's current Market Cap is MXN676,718 Mil. Based on the distribution chart, Haleon ranks #22 out of 1023 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Haleon has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Haleon's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Haleon ranks #22 out of 1023 companies for Market Cap. This places Haleon in the top 2% of its industry — outperforming the majority of peers. The industry median Market Cap is 207.38. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 207.38, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Haleon and its competitors. For the Drug Manufacturers industry, the median Market Cap is 207.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haleon's current Market Cap is MXN676,718 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haleon stock overvalued right now?
Haleon (MEX:HLNN) has a current Market Cap of MXN676,718 Mil. The stock's GF Value™ is MXN107.88, compared to a current price of MXN99.17 — trading 8.1% below its estimated fair value. The current Market Cap is MXN676,718 Mil. Haleon's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Haleon (MEX:HLNN), the current Market Cap is MXN676,718 Mil as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Haleon (MEX:HLNN) Overvalued in 2026?

Based on GuruFocus' analysis, Haleon stock appears to be undervalued. The current stock price of MXN99.17 is trading 8.1% below its estimated GF Value™ of MXN107.88.

Key valuation signals for MEX:HLNN:

  • Market Cap: MXN676,718 Mil
  • GF Value™: MXN107.88 vs. price of MXN99.17 (8.1% below fair value)
  • GF Score™: 74/100 with 3 warning signs

No single metric tells the full story. See the MEX:HLNN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Haleon Business Description

Address The Heights, Building 5, First Floor, Weybridge, Surrey, GBR, KT13 0NY
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
74GF Score

Get the complete analysis for MEX:HLNN

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN99.17
Price
MXN107.88
GF Value